Ra Medical Systems, Inc. (RMED)
(Delayed Data from NYSE)
$4.04 USD
-0.36 (-8.18%)
Updated May 3, 2019 03:59 PM ET
After-Market: $4.04 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$4.04 USD
-0.36 (-8.18%)
Updated May 3, 2019 03:59 PM ET
After-Market: $4.04 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Will Ra Medical Systems, Inc. (RMED) Report Negative Q4 Earnings? What You Should Know
by Zacks Equity Research
Ra Medical Systems, Inc. (RMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ra Medical Systems, Inc. (RMED) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Ra Medical Systems, Inc. (RMED) delivered earnings and revenue surprises of -152.94% and 125.00%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Ra Medical Systems Inc (RMED) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Ra Medical Systems Inc (RMED) delivered earnings and revenue surprises of -166.67% and -9.01%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
New Strong Buy Stocks for April 27th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
The Zacks Analyst Blog Highlights: Eloxx Pharmaceuticals, BGC Partners, SharpSpring, Ra Medical Systems and American States Water
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Eloxx Pharmaceuticals, BGC Partners, SharpSpring, Ra Medical Systems and American States Water
5 Stocks to Gain the Most With the Economy Set to Reopen
by Zacks Equity Research
These five stocks are poised to grow with the guidelines laid out to reopen the economy, as coronavirus pandemic dissipates.